TCF7L2 is a transcription factor in the Wnt signaling pathway and the strongest known genetic risk factor for type 2 diabetes (GWAS). In a sports context, its role is indirect: variants affect insulin secretion and glucose homeostasis, which could theoretically influence endurance performance and recovery. However, direct sport-specific studies demonstrating a clear causal effect on strength, endurance, or injury risk are lacking. The evidence is mechanistic—based on metabolic pathways—not directly transferable to athletic performance. Consumer DNA tests often list TCF7L2 under 'weight management' or 'carbohydrate metabolism,' but the effect size is small and not deterministic. Adjusting diet or training solely based on this gene is not evidence-based. Measured blood glucose levels and individual tolerance are more relevant. Caveat: The diabetes association is robust, but for athletes without metabolic impairment, the practical utility is unclear. Supplement or diet recommendations from genetic tests should be viewed critically.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-5f6b968f71eb9c482ff0932b